Onconetix, Inc. Warrants and Rights Outstanding
Onconetix, Inc. (ONCO) had Warrants and Rights Outstanding of $12.81 million as of 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:WarrantsAndRightsOutstanding · last filed 2025-11-13
- 2025-09-30: Warrants and Rights Outstanding $12.81M.
- 2025-06-30: Warrants and Rights Outstanding $53.11K.
- 2025-03-31: Warrants and Rights Outstanding $52.88K.
- 2024-12-31: Warrants and Rights Outstanding $43.09K.
| Period end | Warrants and Rights Outstanding |
|---|---|
| 2025-09-30 | $12.81M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $53.11K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $52.88K 10-Q · filed 2025-06-12 |
| 2024-12-31 | $43.09K 10-Q · filed 2025-08-14 |
| 2024-09-30 | $125.00K 10-Q · filed 2024-12-10 |
| 2023-12-31 | $2.64K 10-K · filed 2025-06-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |